Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

October 29, 2021

Study Completion Date

January 29, 2022

Conditions
UveitisBiotherapy
Interventions
DRUG

Anakinra

Anakinra (100 mg/day subcutaneously) (n=40) for 16 weeks

DRUG

Tocilizumab

Tocilizumab (162 mg/7 days subcutaneously) (n=40) for 16 weeks.

DRUG

Adalimumab

Adalimumab (40mg/14 days subcutaneously) (n=40) for 16 weeks

Trial Locations (27)

75013

Hopital la pitié salpetriere - Médecine interne 1, Paris

Unknown

Hopital Avicenne - CRC, Bobigny

Hopital Avicenne - Ophtalmologie, Bobigny

Hopital Avicenne- Médecine interne, Bobigny

Hopital Pellegrin, Bordeaux

Hopital Saint André - Médecine interne, Bordeaux

CHU Clermont-Ferrand - Hopital Gabriel Montpied - Médecine interne, Clermont-Ferrand

CHU Clermont-Ferrand - Hopital Gabriel Montpied - Ophtalmologie, Clermont-Ferrand

CHU Dijon Bourgogne -Ophtalmologie, Dijon

CHU Dijon Bourgogne Médecine Interne et Maladies Systémiques - Médecine 2 / SOC 2, Dijon

HCL - Hôpital de la Croix Rousse - Médecine interne, Lyon

HCL - Hôpital de la Croix Rousse - Ophtalmologie, Lyon

CHRU de Nancy - Médecine interne, Nancy

CHRU de Nancy, Nancy

CHNO des Quinze Vingt - Médecine interne, Paris

CHNO des Quinze Vingt - Ophtalmologie, Paris

CHNO des Quinze Vingt, Paris

Hopital Pitié Salpetriere, Paris

Hopital Rotchild - Médecine interne, Paris

Hopital Rotchild - Ophtalmologie, Paris

Hôpital de la pitié salpêtrière - Ophtalmologie, Paris

CHRU de Rennes Hopital Sud Médecine interne, Rennes

CHU Rennes - Hopital Ponchaillou - Ophtalmologie, Rennes

CHU Rouen - Hopital Charles Nicolle - Ophtalmologie, Rouen

CHU Rouen - Hopital Charles Nicolle - Médecine interne, Rougé

CHU TOULOUSE - HOPITAL PIERRE PAUL RIQUET - Ophtalmologie, Toulouse

CHU Toulouse - Hopital Rangueil, Toulouse

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02929251 - Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis | Biotech Hunter | Biotech Hunter